These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 18215636)

  • 1. Growth medium selection and its economic impact on plasmid DNA production.
    Danquah MK; Forde GM
    J Biosci Bioeng; 2007 Dec; 104(6):490-7. PubMed ID: 18215636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of growth conditions on plasmid DNA production.
    Silva F; Passarinha L; Sousa F; Queiroz JA; Domingues FC
    J Microbiol Biotechnol; 2009 Nov; 19(11):1408-14. PubMed ID: 19996695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineering of bacterial strains and vectors for the production of plasmid DNA.
    Bower DM; Prather KL
    Appl Microbiol Biotechnol; 2009 Apr; 82(5):805-13. PubMed ID: 19205691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Large-scale production of endotoxin-free plasmids for transient expression in mammalian cell culture.
    Rozkov A; Larsson B; Gillström S; Björnestedt R; Schmidt SR
    Biotechnol Bioeng; 2008 Feb; 99(3):557-66. PubMed ID: 17680665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modified Escherichia coli B (BL21), a superior producer of plasmid DNA compared with Escherichia coli K (DH5alpha).
    Phue JN; Lee SJ; Trinh L; Shiloach J
    Biotechnol Bioeng; 2008 Nov; 101(4):831-6. PubMed ID: 18814292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of plasmid DNA yields during fed-batch culture of a fruR-knockout Escherichia coli strain.
    Ow DS; Yap MG; Oh SK
    Biotechnol Appl Biochem; 2009 Jan; 52(Pt 1):53-9. PubMed ID: 18380624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Automated alkaline lysis for industrial scale cGMP production of pharmaceutical grade plasmid-DNA.
    Urthaler J; Ascher C; Wöhrer H; Necina R
    J Biotechnol; 2007 Jan; 128(1):132-49. PubMed ID: 17129627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimization of isopropanol and ammonium sulfate precipitation steps in the purification of plasmid DNA.
    Freitas SS; Santos JA; Prazeres DM
    Biotechnol Prog; 2006; 22(4):1179-86. PubMed ID: 16889396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasmid DNA purification.
    Stadler J; Lemmens R; Nyhammar T
    J Gene Med; 2004 Feb; 6 Suppl 1():S54-66. PubMed ID: 14978751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasmid DNA production with Escherichia coli GALG20, a pgi-gene knockout strain: fermentation strategies and impact on downstream processing.
    Gonçalves GA; Prather KL; Monteiro GA; Carnes AE; Prazeres DM
    J Biotechnol; 2014 Sep; 186():119-27. PubMed ID: 24995846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developing strategies to increase plasmid DNA production in Escherichia coli DH5α using batch culture.
    Islas-Lugo F; Vega-Estrada J; Alvis CA; Ortega-López J; Del Carmen Montes-Horcasitas M
    J Biotechnol; 2016 Sep; 233():66-73. PubMed ID: 27374404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of fermentation strategy on the characteristics of plasmid DNA production.
    O'Kennedy RD; Ward JM; Keshavarz-Moore E
    Biotechnol Appl Biochem; 2003 Feb; 37(Pt 1):83-90. PubMed ID: 12578555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a robust, versatile, and scalable inoculum train for the production of a DNA vaccine.
    Okonkowski J; Kizer-Bentley L; Listner K; Robinson D; Chartrain M
    Biotechnol Prog; 2005; 21(4):1038-47. PubMed ID: 16080681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rational engineering of Escherichia coli strains for plasmid biopharmaceutical manufacturing.
    Gonçalves GA; Bower DM; Prazeres DM; Monteiro GA; Prather KL
    Biotechnol J; 2012 Feb; 7(2):251-61. PubMed ID: 21913330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mini-scale cultivation method enables expeditious plasmid production in Escherichia coli.
    Grunzel P; Pilarek M; Steinbrück D; Neubauer A; Brand E; Kumke MU; Neubauer P; Krause M
    Biotechnol J; 2014 Jan; 9(1):128-36. PubMed ID: 24130162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomedical application of plasmid DNA in gene therapy: a new challenge for chromatography.
    Sousa F; Passarinha L; Queiroz JA
    Biotechnol Genet Eng Rev; 2010; 26():83-116. PubMed ID: 21415877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancing methacrylate-monolith-based downstream processes to champion plasmid DNA production.
    Danquah MK; Forde GM
    Biotechnol Appl Biochem; 2007 Oct; 48(Pt 2):85-91. PubMed ID: 17868022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineering of Escherichia coli strains for plasmid biopharmaceutical production: scale-up challenges.
    Gonçalves GA; Prather KL; Monteiro GA; Prazeres DM
    Vaccine; 2014 May; 32(24):2847-50. PubMed ID: 24598722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of plasmid size on cellular oxygen demand in Escherichia coli.
    Kay A; O'Kennedy R; Ward J; Keshavarz-Moore E
    Biotechnol Appl Biochem; 2003 Aug; 38(Pt 1):1-7. PubMed ID: 12689338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced plasmid DNA production by enzyme-controlled glucose release and an engineered Escherichia coli.
    Ramírez EA; Velázquez D; Lara AR
    Biotechnol Lett; 2016 Apr; 38(4):651-7. PubMed ID: 26696535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.